Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7344371

Cc1cccc(NC(=O)c2ccc3cc(C=NN)ccc3c2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
RAB9A P51151 6/20 0.50
HTT P42858 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
KCNK3 O14649 7/20 0.47
KCNK9 Q9NPC2 5/20 0.47
NPC1 O15118 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TP53 P04637 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 1/20 0.46
KCNH2 Q12809 1/20 0.46
PLAU P00749 1/20 0.44
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7344358 1.00 MEN1 (0.50) MEN1KMT2ARAB9AHTTRXFP1
Trifluoroacetic Acid SCHEMBL7338119 0.83 PTGS1 (0.48) MEN1KMT2APOLBPLAU
Trifluoroacetic Acid SCHEMBL7338135 0.83 PTGS1 (0.48) MEN1KMT2APOLBPLAU
Trifluoroacetic Acid SCHEMBL7344126 0.82 PLAU (0.58) KMT2ARAB9ANPC1PLAU
Trifluoroacetic Acid SCHEMBL7344120 0.82 PLAU (0.58) KMT2ARAB9ANPC1PLAU
Trifluoroacetic Acid SCHEMBL7344364 0.82 PLAU (0.65) MEN1KMT2ARAB9AHTTRXFP1
Trifluoroacetic Acid SCHEMBL7335899 0.80 PLAU (0.49) MEN1KMT2ARAB9ANPC1PLAU
SCHEMBL7337311 0.80 PLAU (0.58) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL7337325 0.80 PLAU (0.58) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL7336457 0.80 NPC1 (0.53) MEN1KMT2ARAB9ANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 MEN1 1137/4885KMT2A 4585/4885RAB9A 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.